/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
. Due to this business has low gross profit margin, to build up more sales revenue will result in good net profit. Sales revenue The Company had total sales revenue of Baht 945.6 million in Q1/2020
Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 1 of 16 Executive Summary CPN’s total revenue and net profit continues to grow according to its business plan
Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 1 of 16 Executive Summary CPN’s total revenue and net profit continues to grow according to its business plan
Central Retail Corporation Public Company Limited Page 1 20 February 2020 Re: Management Discussion and Analysis Operating results for the year ended December 31, 2018 To: President The Stock
No. MVP005/2020 21 February 2020 Subject: Management Discussion and Analysis for the year ended 31 December 2019 To: President and Manager The Stock Exchange of Thailand M Vision Public Company
0.88% increase due to the increasing in investment in associated company of 9.30 million baht from better earning of associated company and the increasing investment in associated company. Plus the
there are sold waste form production. 1.3 In Q2-2017, The Selling expenses increase amount of 11 Million Baht from the same period equivalent 16%. As The company expand international market. and
at ฿ 5.92 million. Because in 2017 the company invested excess liquidity in short-term investment and gained ฿ 34.84 million. Matichon and its affiliated companies are trying to increase revenue
increase was mainly from Bangkok Expressway and Metro Public Company Limited (BEM)’s gain on fair value adjustment of investment due to reclassification in the amount of Baht 2,030 Million, net of corporate